RecoVet GmbH – Trademark Portfolio

Entity Type: 98

RecoVet GmbH holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RECOVET, RENALTAN, and RECOACTIV.

Gletzower Landstr. 4

19217 Rehna

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

RECOVET
RECOVET
Registered 2024
RECOACTIV
RECOACTIV
Registered 2024
RENALTAN
RENALTAN
Registered 2024

Trademark Classifications

RecoVet GmbH's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

31
Natural Agricultural Products (3 filings)

Raw and unprocessed agricultural, aquacultural, horticultural and forestry products

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does RecoVet GmbH have?

RecoVet GmbH has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does RecoVet GmbH file in?

RecoVet GmbH files trademarks across 2 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.

What are RecoVet GmbH's most well-known trademarks?

RecoVet GmbH's registered trademark portfolio includes well-known marks such as RECOVET, RENALTAN, and RECOACTIV. These are among 3 currently registered trademarks in the portfolio.

What is RecoVet GmbH's trademark registration success rate?

RecoVet GmbH has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.